Peter Guenter
Förmögenhet: 13 754 $ per 2026-07-31
Förmögenhet: 13 754 $ per 2026-07-31
Peter Guenter is currently Director at Ipsen SA since 2026, Director at Vicore Pharma Holding AB since 2026, and Director at the European Federation of Pharmaceutical Industries & Assns.
Formerly, Mr. Guenter was Chief Executive Officer & Director at Almirall SA from 2017 to 2020, Member-Management Board & CEO-Healthcare at Merck KGaA from 2021 to 2025, Chief Executive Officer at Merck Healthcare KGaA, Chairman-Supervisory Board at Sanofi-Aventis Deutschland GmbH, Independent Non-Executive Director at Lakefront Biotherapeutics from 2019 to 2025, EVP, General Manager-Diabetes & Cardiovascular at Sanofi from 2013 to 2017, and Executive Vice President at Smithkline Beecham.
Education includes graduation from Ghent University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-31 | 501 ( 0 % ) | 13 754 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| IPSEN | Direktör/Styrelseledamot | 2026-01-28 |
| VICORE PHARMA HOLDING AB | Direktör/Styrelseledamot | 2026-05-07 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Direktör/Styrelseledamot | 2025-07-28 |
| MERCK KGAA | Företagsledare/Principal | 2025-06-01 |
| ALMIRALL, S.A. | Verkställande Direktör | 2020-12-31 |
| SANOFI | Företagsledare/Principal | 2017-08-01 |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Merck KGaA
Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Ipsen SA
Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Almirall SA
Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products & provides research and development services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Smithkline Beecham | |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Merck Healthcare KGaA
Merck Healthcare KGaA Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of science-driven therapies for cancer patients | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån